<DOC>
	<DOCNO>NCT00000317</DOCNO>
	<brief_summary>The purpose study develop model early Phase II test potential medication cocaine dependence : amoxapine , risperidone agent . The study control pilot trial risperidone opiate-dependent patient methadone maintenance . The study explore whether risperidone reduce cocaine use , cocaine craving , cocaine subjective effect patient methadone maintenance abuse cocaine whether acceptable side effect profile . This</brief_summary>
	<brief_title>Early Phase II Trials Cocaine Medication Development - 1</brief_title>
	<detailed_description>This 18-week prospective , randomize , placebo-controlled crossover design placebo lead-in phase terminal placebo phase . After two week single-blind placebo , patient randomly assign one two schedule medication : 2 Week Baseline Weeks 1-6 Weeks 7-12 Weeks 13-18 Group 1 placebo risperidone placebo placebo Group 2 placebo placebo risperidone placebo The first 6-week phase provide initial double-blind medication-placebo comparison . In second six-week phase ( week 7-12 ) , patient cross opposite treatment . During week 13-18 , Group 1 patient remain placebo Group 2 patient taper risperidone placebo . For six week end trial , patient offer routine clinical treatment counsel psychiatrist visit need . Medication dosage titrate upwards fixed-flexible schedule maximum dose 4 mg per day . Medication begin Â½ mg risperidone 3 day , 1 mg four day , 2 mg per day week 2 , 3 mg per day week 3 , 4 mg per day week 4-6 . The titration schedule risperidone week 7-12 week 1-6 . In addition treatment usual , patient receive modified manual-guided relapse prevention counsel program weekly meeting last approximately 20 minute ; session provide cognitive behavioral skill find helpful patient reduce cocaine use .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<criteria>Inclusion : 1. good stand methadone maintenance program 2 . DSMIV criterion cocaine dependence abuse 3. use cocaine least 4 time last month 4. able give inform consent Exclusion criterion 1. currently meet DSMIV criterion Major depression dysthymia 2. meet DSMIV criterion attention deficit hyperactivity disorder , bipolar disorder , schizophrenia psychotic disorder 3. history seizure 4. history allergic reaction risperidone 5. chronic organic mental disorder 6. significant current suicidal risk 7. pregnancy , lactation failure use adequate birth control ( female ) 8. unstable physical disorder may make participation hazardous 9. coronary vascular disease 10. cardiac conduction system disease indicate QRS duration &gt; /= 0.11 11. current use prescribe psychotropic medication 12. history failure respond previous adequate trial risperidone 13. history neuroleptic malignant syndrome , tardive dyskinesia , severe extrapyramidal reaction neuroleptic medication 14. current DSMIV criterion another substance dependence nicotine .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>